» Articles » PMID: 33179015

Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

Abstract

Cancer cells display DNA hypermethylation at specific CpG islands in comparison to their normal healthy counterparts, but the mechanism that drives this so-called CpG island methylator phenotype (CIMP) remains poorly understood. Here, we show that CpG island methylation in human T-cell acute lymphoblastic leukemia (T-ALL) mainly occurs at promoters of Polycomb Repressor Complex 2 (PRC2) target genes that are not expressed in normal or malignant T-cells and which display a reciprocal association with H3K27me3 binding. In addition, we revealed that this aberrant methylation profile reflects the epigenetic history of T-ALL and is established already in pre-leukemic, self-renewing thymocytes that precede T-ALL development. Finally, we unexpectedly uncover that this age-related CpG island hypermethylation signature in T-ALL is completely resistant to the FDA-approved hypomethylating agent Decitabine. Altogether, we here provide conceptual evidence for the involvement of a pre-leukemic phase characterized by self-renewing thymocytes in the pathogenesis of human T-ALL.

Citing Articles

Liquid-liquid phase separation in diseases.

Zhang X, Yuan L, Zhang W, Zhang Y, Wu Q, Li C MedComm (2020). 2024; 5(7):e640.

PMID: 39006762 PMC: 11245632. DOI: 10.1002/mco2.640.


Transient Differentiation-State Plasticity Occurs during Acute Lymphoblastic Leukemia Initiation.

Poort V, Hagelaar R, van Roosmalen M, Trabut L, Buijs-Gladdines J, van Wijk B Cancer Res. 2024; 84(16):2720-2733.

PMID: 38885294 PMC: 11325147. DOI: 10.1158/0008-5472.CAN-24-1090.


Building Minimized Epigenetic Clock by iPlex MassARRAY Platform.

Davydova E, Perenkov A, Vedunova M Genes (Basel). 2024; 15(4).

PMID: 38674360 PMC: 11049545. DOI: 10.3390/genes15040425.


Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.

De Coninck S, Roels J, Lintermans B, TSas S, Taghon T, Curtis D Blood Adv. 2024; 8(11):2646-2649.

PMID: 38536906 PMC: 11157202. DOI: 10.1182/bloodadvances.2023011970.


Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.

Abdulla H, Alserihi R, Flensburg C, Abeysekera W, Luo M, Gray D J Exp Med. 2023; 220(6).

PMID: 36920307 PMC: 10037042. DOI: 10.1084/jem.20212383.


References
1.
Manser M, Sater M, Schmid C, Noreen F, Murbach M, Kuster N . ELF-MF exposure affects the robustness of epigenetic programming during granulopoiesis. Sci Rep. 2017; 7:43345. PMC: 5339735. DOI: 10.1038/srep43345. View

2.
Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

3.
Minderjahn J, Schmidt A, Fuchs A, Schill R, Raithel J, Babina M . Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nat Commun. 2020; 11(1):402. PMC: 6972792. DOI: 10.1038/s41467-019-13960-2. View

4.
Kimura S, Seki M, Kawai T, Goto H, Yoshida K, Isobe T . DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes. Leukemia. 2019; 34(4):1163-1168. DOI: 10.1038/s41375-019-0626-2. View

5.
Schmidl C, Rendeiro A, Sheffield N, Bock C . ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors. Nat Methods. 2015; 12(10):963-965. PMC: 4589892. DOI: 10.1038/nmeth.3542. View